The level of oxygen in our body tissues gradually reduces with age. It results in a decline of our main functions: mobility, cognition and immunity. This in turn makes us more susceptible to different diseases, which can reduce tissue oxygen faster and to a deeper level.
To address these health problems our team has developed a line of products to prevent or even reverse reduction in tissue oxygenation. The products are based on proprietary technologies and have been clinically validated on target market groups of people.
A significant number of these products, with a value exceeding £4.5 million, have already been manufactured and are ready for market.
The funds we raise would be used to hire or contract marketing, business development expertise and selling support expertise.